Use of Nitric Oxide Synthase Inhibitors for the Treatment of Life-Threatening Hypotension in the Septic Syndrome

Petros, A J; Bennett, ED; Vallance, P

doi:10.1042/cs082001Pb

Article navigation

Conference Abstract| March 01 1992

Use of Nitric Oxide Synthase Inhibitors for the Treatment of Life-Threatening Hypotension in the Septic Syndrome

A J Petros

Intensive Therapy Unit and Department of Pharmacology & Clinical Pharmacology, St. George's Hospital Medical School, London SW17 ORE, Endland

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

ED Bennett

Intensive Therapy Unit and Department of Pharmacology & Clinical Pharmacology, St. George's Hospital Medical School, London SW17 ORE, Endland

Search for other works by this author on:

This Site

PubMed

Google Scholar

;

P Vallance

Intensive Therapy Unit and Department of Pharmacology & Clinical Pharmacology, St. George's Hospital Medical School, London SW17 ORE, Endland

Search for other works by this author on:

This Site

PubMed

Google Scholar

Clin Sci (Lond) (1992) 82 (s26): 1P.

https://doi.org/10.1042/cs082001Pb

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press
5th Floor, 90 High Holborn,
London WC1V 6LJ

Portland Press Tel
+44 (0)20 3880 2795
Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Privacy and cookies
Accessibility

Use of Nitric Oxide Synthase Inhibitors for the Treatment of Life-Threatening Hypotension in the Septic Syndrome

Article PDF first page preview

Cited By

Get Email Alerts

CONNECT

EXPLORE

Use of Nitric Oxide Synthase Inhibitors for the Treatment of Life-Threatening Hypotension in the Septic Syndrome

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Cited By

Get Email Alerts

Related Articles

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only